Thao P. Le

Array ( [id] => 10267414 [patent_doc_number] => 20150152411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/403557 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40110 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656480 [patent_doc_number] => 20160002624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/401761 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34648 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13077137 [patent_doc_number] => 10058623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-28 [patent_title] => Compositions and methods for modulating UTRN expression [patent_app_type] => utility [patent_app_number] => 14/401196 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 139778 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367360 [patent_doc_number] => 20150252364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING SMN GENE FAMILY EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/401194 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 42147 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13763977 [patent_doc_number] => 10174323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Compositions and methods for modulating ATP2A2 expression [patent_app_type] => utility [patent_app_number] => 14/401214 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32393 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10274165 [patent_doc_number] => 20150159161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING PTEN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/401227 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 67631 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13763961 [patent_doc_number] => 10174315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Compositions and methods for modulating hemoglobin gene family expression [patent_app_type] => utility [patent_app_number] => 14/401201 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20545 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10267413 [patent_doc_number] => 20150152410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING MECP2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/401237 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54865 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248533 [patent_doc_number] => 20150133529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING BDNF EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/401234 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47200 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9562042 [patent_doc_number] => 20140179755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'USE OF VEGFR1 AS A BIOMARKER' [patent_app_type] => utility [patent_app_number] => 13/894650 [patent_app_country] => US [patent_app_date] => 2013-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15190 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13894650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212016 [patent_doc_number] => 20140011193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'APTAMER-BASED LATERAL FLOW ASSAY AND ASSOCIATED METHODS' [patent_app_type] => utility [patent_app_number] => 13/894161 [patent_app_country] => US [patent_app_date] => 2013-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6927 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13894161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11507547 [patent_doc_number] => 09598694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-21 [patent_title] => 'Micro-RNAs involved in macular degeneration' [patent_app_type] => utility [patent_app_number] => 14/398330 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 80 [patent_no_of_words] => 28933 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9930915 [patent_doc_number] => 20150079107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'AGENTS AND METHODS FOR TREATING AND PREVENTING SEBORRHEIC KERATOSIS' [patent_app_type] => utility [patent_app_number] => 14/395737 [patent_app_country] => US [patent_app_date] => 2013-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16358 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11178172 [patent_doc_number] => 09410156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => 'Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions' [patent_app_type] => utility [patent_app_number] => 14/381679 [patent_app_country] => US [patent_app_date] => 2013-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 22 [patent_no_of_words] => 66450 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9108553 [patent_doc_number] => 20130281685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'iRNA AGENTS WITH BIOCLEAVABLE TETHERS' [patent_app_type] => utility [patent_app_number] => 13/849017 [patent_app_country] => US [patent_app_date] => 2013-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 63149 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13849017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739490 [patent_doc_number] => 20140275209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'WOUND HEALING COMPOSITIONS AND TREATMENTS' [patent_app_type] => utility [patent_app_number] => 13/844762 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18105 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9817730 [patent_doc_number] => 08927516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/836414 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 13229 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11198331 [patent_doc_number] => 09428534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Antisense design' [patent_app_type] => utility [patent_app_number] => 13/797913 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 42 [patent_no_of_words] => 19539 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13797913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9033815 [patent_doc_number] => 20130236453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'Methods and Compositions for Modulating Acute Graft-versus-Host Disease using miR-155 Specific Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/795879 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21665 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13795879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940591 [patent_doc_number] => 20130190388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'Methods and Compositions Related to DLK-1 and the P38 MAPK Pathway in Nerve Regeneration' [patent_app_type] => utility [patent_app_number] => 13/792181 [patent_app_country] => US [patent_app_date] => 2013-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22651 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13792181 [rel_patent_id] =>[rel_patent_doc_number] =>)